MicroTransponder recently announced positive real-world outcomes for its Vivistim vagus nerve stimulation (VNS) system.
RenovoRx (Nasdaq:RNXT) announced that it priced an underwritten public offering of common stock worth proceeds of $12.1 ...
BlueWind Medical today announced two-year results from a study of its Revi implantable tibial neuromodulation (iTNM) system.
Neuronetics (Nasdaq:STIM) announced today that it priced an underwritten public offering of common stock at approximately $18 ...
Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).
The FDA labeled a recall of integrated arterial catheters made by Medline Class I, the most serious kind of recall.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results